May 10, 2022
Via: Investing.comPfizer Inc (NYSE:PFE) said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co (NYSE:BHVN), making a big bet its ability to boost sales of the top-selling pill in a new class of migraine drugs. The boards […]
April 23, 2024
March 28, 2024